[Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].
D000230:Adenocarcinoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004640:Emetine / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008130:Lomustine / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use; D010166:Palliative Care; D011425:Propionibacterium acnes / Q000276:immunology; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008937:Mitomycins; D001761:Bleomycin; D014750:Vincristine; D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D004640:Emetine; D008727:Methotrexate
Résultats personnels récents dans les cancers bronchiques avancés. Immuno-chimiothérapies palliatives